Question 1

What is the catalog number for RXRA Knockout Cell Line-5637?

Accepted Answer

The catalog number for RXRA Knockout Cell Line-5637 is RK-0656.

Question 2

What sizes are available for RXRA Knockout Cell Line-5637?

Accepted Answer

RXRA Knockout Cell Line-5637 is available in the following size(s): 1x 10^6.

Question 3

Is RXRA Knockout Cell Line-5637 in stock?

Accepted Answer

RXRA Knockout Cell Line-5637 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for RXRA Knockout Cell Line-5637?

Accepted Answer

RXRA Knockout Cell Line-5637 is requires dry ice shipping.

Question 5

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 6

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 7

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

RXRA Knockout Cell Line-5637

Product Specifications

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Lentiviral mouse Slc25a16 shRNA (UAS) - Lentiviral mouse Slc25a16 shRNA (UAS) (100)

Kallistatin/SERPINA4 Rabbit Polyclonal Antibody (Fluoro594)

Bococizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade

Bococizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade

Bococizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade

Pyriproxyfen